TEM

TEM

USD

Tempus AI Inc. Class A Common Stock

$84.490-0.565 (-0.664%)

Prix en Temps Réel

Healthcare
Health Information Services
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$85.055

Haut

$88.880

Bas

$83.940

Volume

8.89M

Fondamentaux de l'Entreprise

Capitalisation Boursière

14.7B

Industrie

Health Information Services

Pays

United States

Statistiques de Trading

Volume Moyen

9.33M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $31.36Actuel $84.490Haut $104.32

Actualités Connexes

BusinessWire

Tempus to Participate in the Stifel 2025 Healthcare Conference

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in New York City. Jim

Voir plus
Tempus to Participate in the Stifel 2025 Healthcare Conference
Analyst Upgrades

Piper Sandler Maintains Neutral on Tempus AI, Raises Price Target to $105

Piper Sandler analyst David Westenberg maintains Tempus AI with a Neutral and raises the price target from $70 to $105.

Voir plus
Piper Sandler Maintains Neutral on Tempus AI, Raises Price Target to $105
Analyst Upgrades

BTIG Maintains Buy on Tempus AI, Raises Price Target to $96

BTIG analyst Mark Massaro maintains Tempus AI with a Buy and raises the price target from $85 to $96.

Voir plus
BTIG Maintains Buy on Tempus AI, Raises Price Target to $96
BusinessWire

Tempus to Report Third Quarter 2025 Financial Results on November 4

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the third quarter of 2025 on November 4, 2025. The company will hold the

Voir plus
Tempus to Report Third Quarter 2025 Financial Results on November 4
BusinessWire

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the European Society for Medical

Voir plus
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
BusinessWire

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.